[Hub]/) : Traits : Impedance of arm (left) : ← →

chr10:64,195,778-65,911,294

Best TWAS P=2.39e-17 · Best GWAS P=8.58e-17 conditioned to 0.0794

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
23	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	NRBF2	0.08	0.02	blup	40	0.04	8.6e-03	8.3	-8.5	2.4e-17	-0.89	0.00	0.90	TRUE
12	The Cancer Genome Atlas	Breast Invasive Carcinoma	NRBF2	0.05	0.06	lasso	2	0.06	5.5e-12	8.3	-8.2	2.3e-16	-1.00	0.00	1.00	FALSE
15	The Cancer Genome Atlas	Glioblastoma Multiforme	NRBF2	0.17	0.09	enet	10	0.13	1.1e-04	8.3	-8.2	3.6e-16	-0.88	0.00	0.96	FALSE
2	GTEx	Brain Frontal Cortex BA9	NRBF2	0.25	0.17	lasso	6	0.16	6.1e-05	8.3	-8.1	4.9e-16	-0.98	0.01	0.98	FALSE
4	GTEx	Esophagus Mucosa	NRBF2	0.14	0.11	lasso	10	0.11	6.4e-08	8.0	-8.1	6.0e-16	-0.95	0.01	0.99	FALSE
10	ROSMAP	Brain Pre-frontal Cortex	NRBF2	0.34	0.46	lasso	5	0.46	3.1e-66	8.3	-8.1	6.5e-16	-0.99	0.00	1.00	FALSE
14	The Cancer Genome Atlas	Glioblastoma Multiforme	JMJD1C	0.11	0.02	blup	87	0.05	1.4e-02	8.2	-8.0	1.0e-15	-0.87	0.01	0.74	FALSE
5	GTEx	Nerve Tibial	NRBF2	0.08	0.09	enet	11	0.06	5.0e-05	8.0	-7.8	4.0e-15	-0.91	0.01	0.99	FALSE
21	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	LOC84989	0.10	0.05	blup	19	0.04	7.7e-03	-6.2	-7.8	5.0e-15	-0.69	0.01	0.36	FALSE
25	The Cancer Genome Atlas	Prostate Adenocarcinoma	NRBF2	0.08	0.09	lasso	6	0.08	9.7e-09	8.2	-7.8	8.1e-15	-0.98	0.00	1.00	FALSE
7	GTEx	Testis	NRBF2	0.14	0.08	lasso	12	0.09	6.7e-05	8.0	-7.6	2.5e-14	-0.96	0.02	0.98	FALSE
18	The Cancer Genome Atlas	Brain Lower Grade Glioma	NRBF2	0.08	0.08	enet	6	0.08	4.3e-09	8.3	-7.6	2.6e-14	-0.98	0.00	1.00	FALSE
26	The Cancer Genome Atlas	Thyroid Carcinoma	NRBF2	0.14	0.10	enet	16	0.09	8.1e-09	8.2	-7.6	3.4e-14	-0.91	0.00	1.00	FALSE
16	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	NRBF2	0.04	0.04	enet	5	0.03	1.3e-04	8.2	-7.6	3.5e-14	-0.97	0.00	0.99	FALSE
3	GTEx	Cells Transformed fibroblasts	JMJD1C	0.09	0.01	enet	18	0.07	8.6e-06	-6.7	-7.6	4.1e-14	-0.62	0.12	0.71	FALSE
22	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	NRBF2	0.18	0.13	enet	11	0.08	2.5e-04	8.2	-7.5	4.6e-14	-0.89	0.00	0.99	FALSE
13	The Cancer Genome Atlas	Colon Adenocarcinoma	NRBF2	0.13	0.10	enet	11	0.09	4.9e-06	8.3	-7.5	5.5e-14	-0.85	0.00	1.00	FALSE
1	GTEx	Brain Cortex	NRBF2	0.30	0.26	enet	24	0.21	1.4e-06	-7.6	-7.5	5.6e-14	-0.95	0.02	0.98	FALSE
9	GTEx	Thyroid	NRBF2	0.11	0.05	lasso	3	0.07	2.5e-06	-4.8	-7.0	2.8e-12	-0.72	0.03	0.97	FALSE
20	The Cancer Genome Atlas	Lung Adenocarcinoma	NRBF2	0.09	0.06	enet	8	0.07	2.7e-08	8.2	-6.8	1.3e-11	-0.94	0.00	1.00	FALSE
17	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	NRBF2	0.10	0.06	lasso	7	0.08	3.5e-09	-3.8	-6.5	9.6e-11	-0.88	0.01	0.99	FALSE
8	GTEx	Testis	JMJD1C-AS1	0.22	0.08	enet	23	0.10	3.7e-05	-6.3	-6.5	1.0e-10	-0.41	0.67	0.04	FALSE
24	The Cancer Genome Atlas	Prostate Adenocarcinoma	JMJD1C	0.04	0.01	blup	88	0.01	9.7e-03	8.2	-6.1	1.1e-09	-0.87	0.01	0.91	FALSE
11	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	NRBF2	0.07	0.04	blup	42	0.02	7.3e-03	8.2	-6.0	2.0e-09	-0.84	0.00	0.98	FALSE
6	GTEx	Stomach	NRBF2	0.09	0.04	lasso	6	0.03	1.6e-02	-3.3	-5.7	1.1e-08	-0.73	0.08	0.42	FALSE
19	The Cancer Genome Atlas	Brain Lower Grade Glioma	REEP3	0.04	0.04	blup	59	0.05	1.8e-06	-3.8	5.7	1.5e-08	0.80	0.03	0.97	FALSE